These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38978143)

  • 1. Correlation between serum bilirubin, blood uric acid, and C-reactive protein and the severity of chronic obstructive pulmonary disease.
    Zhao T; Lv T
    J Health Popul Nutr; 2024 Jul; 43(1):105. PubMed ID: 38978143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of the Serum KL-6 with Severity and Prognosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Wang Y; Fei J; Xu J; Cheng ZY; Ma YC; Wu JH; Yang J; Zhao H; Fu L
    Lung; 2024 Jun; 202(3):245-255. PubMed ID: 38743087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
    Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
    Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotyping COPD exacerbations using imaging and blood-based biomarkers.
    Alotaibi NM; Chen V; Hollander Z; Hague CJ; Murphy DT; Leipsic JA; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
    Int J Chron Obstruct Pulmon Dis; 2018; 13():217-229. PubMed ID: 29386890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Eosinophil-to-Lymphocyte Ratio (ELR) as Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
    Liao QQ; Mo YJ; Zhu KW; Gao F; Huang B; Chen P; Jing FT; Jiang X; Xu HZ; Tang YF; Chu LW; Huang HL; Wang WL; Wei FN; Huang DD; Zhao BJ; Chen J; Zhang H
    Int J Chron Obstruct Pulmon Dis; 2024; 19():501-518. PubMed ID: 38414718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Monocyte-to-Lymphocyte Ratio (MLR) as Biomarkers in Diagnosis Evaluation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Study.
    Cai C; Zeng W; Wang H; Ren S
    Int J Chron Obstruct Pulmon Dis; 2024; 19():933-943. PubMed ID: 38646605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.
    Baumann S; Huseynov A; Koepp J; Jabbour C; Behnes M; Becher T; Renker M; Lang S; Borggrefe M; Lehmann R; Akin I
    Angiology; 2016 Mar; 67(3):272-80. PubMed ID: 26032849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.
    Francis NA; Gillespie D; White P; Bates J; Lowe R; Sewell B; Phillips R; Stanton H; Kirby N; Wootton M; Thomas-Jones E; Hood K; Llor C; Cals J; Melbye H; Naik G; Gal M; Fitzsimmons D; Alam MF; Riga E; Cochrane A; Butler CC
    Health Technol Assess; 2020 Mar; 24(15):1-108. PubMed ID: 32202490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.
    Gallego M; Pomares X; Capilla S; Marcos MA; Suárez D; Monsó E; Montón C
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2633-2640. PubMed ID: 27799762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid and uric acid to creatinine ratio in the assessment of chronic obstructive pulmonary disease: Potential biomarkers in multicomponent models comprising IL-1beta.
    Rumora L; Hlapčić I; Popović-Grle S; Rako I; Rogić D; Čepelak I
    PLoS One; 2020; 15(6):e0234363. PubMed ID: 32502184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the role of uric acid and uric acid-to-creatinine ratio as a predictive factor of chronic obstructive pulmonary disease exacerbation in 2019.
    Barmehziar S; Fadaii A; Samadian F; Shakiba A; Koolaji S
    Clin Respir J; 2023 Oct; 17(10):1025-1037. PubMed ID: 37643874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application Value of Blood Heparin-Binding Protein in the Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Dong Y; Zhou X; Zhang Y; Liu Y; Zhou X; Ren G; Li Q
    Contrast Media Mol Imaging; 2021; 2021():3800211. PubMed ID: 35024012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.
    Yao C; Liu X; Tang Z
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD.
    Farah R; Ibrahim R; Nassar M; Najib D; Zivony Y; Eshel E
    Panminerva Med; 2017 Sep; 59(3):203-209. PubMed ID: 28185443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between serum amyloid A, C-reactive protein and clinical indices of patients with acutely exacerbated chronic obstructive pulmonary disease.
    Lin TL; Chen WW; Ding ZR; Wei SC; Huang ML; Li CH
    J Clin Lab Anal; 2019 May; 33(4):e22831. PubMed ID: 30666727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Uric Acid Levels and Uric Acid/Creatinine Ratios in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients: Are These Parameters Efficient Predictors of Patients at Risk for Exacerbation and/or Severity of Disease?
    Durmus Kocak N; Sasak G; Aka Akturk U; Akgun M; Boga S; Sengul A; Gungor S; Arinc S
    Med Sci Monit; 2016 Nov; 22():4169-4176. PubMed ID: 27811831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
    Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC
    Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Song W; Wang Y; Tian F; Ge L; Shang X; Zeng Q; Feng N; Fan J; Wang J; Ma X
    Dis Markers; 2021; 2021():8879401. PubMed ID: 33791046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum bilirubin and the risk of chronic obstructive pulmonary disease exacerbations.
    Brown KE; Sin DD; Voelker H; Connett JE; Niewoehner DE; Kunisaki KM;
    Respir Res; 2017 Oct; 18(1):179. PubMed ID: 29065885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.